Blackstone Life Sciences VI - BL L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Apr 2, 2026, it has sold $6,300,000,000 of interests to 1 investor since its first sale in Nov 2025. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Blackstone Life Sciences Associates VI L.P; Chris Placca; Nicholas Galakatos.
- Total raised
- $6,300,000,000Cumulative sales reported on Form D
- Investors
- 1
- First sale
- Nov 7, 2025
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Blackstone Life Sciences Associates VI L.P; Chris Placca; Nicholas Galakatos
- Latest Form D
- Apr 2, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 2, 2026 | Form D/A (amendment) | $6,300,000,000 | 1 | SEC.gov ↗ |
| Nov 20, 2025 | Form D | $3,615,298,293 | 1 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Nov 20, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Blackstone Life Sciences VI - BL L.P.
What is the minimum investment for Blackstone Life Sciences VI - BL L.P.?
Blackstone Life Sciences VI - BL L.P.'s latest Form D, filed Apr 2, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Blackstone Life Sciences VI - BL L.P.?
Blackstone Life Sciences VI - BL L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Blackstone Life Sciences VI - BL L.P. raised?
Blackstone Life Sciences VI - BL L.P. reports $6,300,000,000 sold from 1 investor on its Form D filed Apr 2, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Blackstone Life Sciences VI - BL L.P. based?
Blackstone Life Sciences VI - BL L.P. is based in New York, New York.
When did Blackstone Life Sciences VI - BL L.P. launch?
Blackstone Life Sciences VI - BL L.P. reports its first sale in Nov 2025.
Size compared with every private equity fund
Raised more than 99% of the 3,661 private equity funds based in New York, and more than 99% of all 8,931 that report sales.